0001782226-22-000002.txt : 20221011 0001782226-22-000002.hdr.sgml : 20221011 20221011171807 ACCESSION NUMBER: 0001782226-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221011 DATE AS OF CHANGE: 20221011 EFFECTIVENESS DATE: 20221011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: i2O Therapeutics, Inc. CENTRAL INDEX KEY: 0001782226 IRS NUMBER: 841743853 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-461414 FILM NUMBER: 221304790 BUSINESS ADDRESS: STREET 1: 13250 VIA ARRIBA DRIVE CITY: SARATOGA STATE: CA ZIP: 95070 BUSINESS PHONE: 408-476-1904 MAIL ADDRESS: STREET 1: 13250 VIA ARRIBA DRIVE CITY: SARATOGA STATE: CA ZIP: 95070 D 1 primary_doc.xml X0708 D LIVE 0001782226 i2O Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 408-476-1904 DELAWARE None None Corporation true 2019 Ravi Srinivasan c/o i2oTherapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Samir Mitragotri c/o i2oTherapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Anthony Aiudi c/o i2o Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Christopher Gagliardi c/o i2o Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Kurt Graves c/o i2o Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2022-07-18 false true false 0 42032225 33539921 8492304 $26,007,689.02 new money, $7,532,232.86 conversion of debt false 17 0 0 0 false i2O Therapeutics, Inc. /s/ Ravi Srinivasan Ravi Srinivasan President 2022-10-11